| Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More | Frank Vinluan | 09/11/20 | National |
| Satsuma Pharma’s Migraine Drug Fails to Beat Placebo in Phase 3 Test | Frank Vinluan | 09/10/20 | San Francisco |
| SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M | Frank Vinluan | 09/12/19 | San Francisco |
| Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More | Frank Vinluan | 08/23/19 | National |
| Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs | Frank Vinluan | 08/16/19 | New York |
| Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More | Frank Vinluan | 04/26/19 | National |
